The Authors: Dr José M. Porcel is a Professor of Medicine, Chief of the Department of Internal Medicine at Arnau de Vilanova University Hospital and Head of the Pleural Diseases Unit at the Biomedical Research Institute in Lleida, Spain (IRBLLEIDA). He is the ACCP Regent for Spain, Deputy Editor for Respirology and Editor of the International Pleural Newsletter. His clinical and research interests focus primarily on pleural effusions. Dr John P. Diaz is an Assistant Professor of Obstetrics and Gynecology in the Division of Gynecologic Oncology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. He is interested in novel surgical techniques in the management of gynaecologic malignancies. Dr Dennis S. Chi is the Deputy Chief of the Gynecology Service, Director of the Gynecologic Oncology Fellowship, Pelvic Reconstruction Clinical Research Fellowship, and International Gynecologic Oncology Fellowship programs at the Memorial Sloan-Kettering Cancer Center of New York. He has published extensively on surgical procedures for treating gynaecologic malignancies and is an internationally recognized authority in the field.
Clinical implications of pleural effusions in ovarian cancer
Article first published online: 21 SEP 2012
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology
Volume 17, Issue 7, pages 1060–1067, October 2012
How to Cite
PORCEL, J. M., DIAZ, J. P. and CHI, D. S. (2012), Clinical implications of pleural effusions in ovarian cancer. Respirology, 17: 1060–1067. doi: 10.1111/j.1440-1843.2012.02177.x
- Issue published online: 21 SEP 2012
- Article first published online: 21 SEP 2012
- Accepted manuscript online: 28 MAR 2012 04:44AM EST
- Received 3 February 2012; invited to revise 6 March 2012; revised 11 March 2012; accepted 19 March 2012 (Associate Editor: Ioannis Kalomenidis).
- 10Meig's syndrome. Int. Pleural Newsl. 2011; 9: 10., , et al.
- 11Clinical experience of pseudo-Meig's syndrome due to colon cancer. World J. Gastroenterol. 2011; 17: 3263–6., , et al.
- 17Bristow R, Amstrong D (eds). Ovarian Cancer. Saunders Elsevier, Philadelphia, PA, 2010.
- 20Malignant effusions. In: Maskell N, Millar A (eds) Oxford Desk Reference: Respiratory Medicine. Oxford University Press, Oxford, 2009; 342–5., .
- 22Ganjei-Azar P, Jordà M, Krishan A (eds). Effusion Cytology. A Practical Guide to Cancer Diagnosis. Demos Medical, New York, 2011.
- 23Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells. Diagn. Cytopathol. 2010; 38: 9–14., , .
- 29Epithelial ovarian cancer. J. Natl Compr. Canc. Netw. 2011; 9: 82–113., , et al.
- 34Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer. Anticancer Res. 2011; 31: 4043–9., , et al.
- 36Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst. Rev. 2011; (8): CD007565., , et al.
- 38Cytoreductive surgery for advanced ovarian cancer: Quo Vadis? Oncology (Williston Park) 2011; 25: 928–34., , .